Comparison of the Classification Performance of CA-125, the Proof-of-Principle and the Final Classifier.

*Since the cut-off value of 35 IU/ml is already established, the complete data set, excluding duplicates was used to assess the predictive value of CA-125. #sensitivity for all stage I samples only, excluding duplicates. ‡sensitivity and specificity determined using the 136 ovarian cancer and 149 non-ovarian cancer samples, excluding duplicates, not used in development of the 7-anlayte classifier. ¶sensitivity and specificity determined using the 115 ovarian cancer and 130 non-ovarian cancer samples, excluding duplicates, not used in development of the 11-anlayte classifier. 95% CI, 95% confidence interval for result.